Novo Nordisk A/S (NVO)
49.37
+1.73
(+3.63%)
USD |
NYSE |
Feb 09, 16:00
49.14
-0.23
(-0.47%)
After-Hours: 20:00
Novo Nordisk EPS Diluted (Quarterly) : 0.9419 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ascendis Pharma A/S | -1.173 |
| Evaxion AS | -0.2862 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Viking Therapeutics, Inc. | -0.8083 |
| DBV Technologies SA | -1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.191B |
| Revenue (Quarterly) | 12.33B |
| Total Expenses (Quarterly) | 8.143B |
| Enterprise Value | 235.89B |
| Gross Profit Margin (Quarterly) | 80.86% |
| Profit Margin (Quarterly) | 33.98% |
| Earnings Yield | 7.02% |
| Operating Earnings Yield | 8.76% |
| Normalized Earnings Yield | 7.024 |